Viyash Scientific share news, announcements and annual reports
NSE: VIYASHBSE: 512529Pharmaceuticals & BiotechnologySmall Cap
Viyash Scientific Limited · Formerly Sequent Scientific · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1990 on BSE, Mar 2016 on NSE
Last close ₹218.39down ₹6.16 (2.74%)BSE ₹218.50
Share price at the NSE close on 30 Oct 2026. Previous close ₹224.55.
30 Oct: open ₹224.59, high ₹225.84, low ₹217.35
52-week range of traded prices to 30 Oct 2026
₹178.13Low, 23 Mar 2026₹298.00High, 6 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,645 Cr598th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,13,10753.2% delivered
Viyash Scientific share news and announcements
593 announcements, routine notices left out, newest first. Page 4 of 12.
Nov 2024
6 Nov · Analysts
5 Nov
Oct 2024
30 Oct
29 Oct · Meeting
28 Oct · Management
17 Oct · Updates
9 Oct · Analysts
Sep 2024
26 Sep · Analysts
26 Sep · Business
18 Sep · Meeting
Aug 2024
14 Aug · Results
14 Aug · Board meeting
9 Aug · Analysts
9 Aug · Board meeting
Jul 2024
16 Jul · Analysts
14 Jul · Meeting
11 Jul · Legal
Significant increase in volume has been observed in Sequent Scientific Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.9 Jul · Analysts
5 Jul · Analysts
Jun 2024
13 Jun · Meeting
May 2024
23 May · Updates
15 May · Board meeting
15 May · Results
13 May · Analysts
Apr 2024
29 Apr · Legal
Exchange has sought clarification from Sequent Scientific Limited with respect to announcement dated 10-Apr-2024, regarding providing guarantee and pledging of equity shares of its Indian Subsidiaries. On basis of above the Company is required to clarify following: a) name of party for which such guarantees or indemnity or surety was given; b) whether the promoter/ promoter group/ group companies have any interest in this transaction? If yes, nature of interest and details thereof and whether the same is done at arm's length; c) brief details of such guarantee or indemnity or becoming a surety viz. brief details of agreement entered (if any) including significant terms and conditions, including amount of guarantee; d) impact of such guarantees or indemnity or surety on listed entity. The response of the Company is awaited.16 Apr · Disclosure
Mar 2024
Feb 2024
13 Feb · Board meeting
13 Feb · Results
12 Feb · Analysts
8 Feb · Updates
6 Feb · Meeting
6 Feb · Analysts